Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded by Wu Yiling, an academician of China Academy of Engineering. Mainly engaged in research and development, production and sales of Chinese patent medicines. At present, it is famous for its Lianhua Qingwen capsule products.
The production bases built by the company in Shijiazhuang, Hengshui, Daxing, Miyun and other places in Hebei Province have created a perfect production layout, ensured product supply, introduced advanced equipment and pharmaceutical technology at home and abroad, created a comprehensive quality control system in line with international standards, established a strong marketing network and academic marketing team, and formed three business sectors: scientific and technological Chinese medicine, biochemical medicine and health industry.
Honors won by Yiling Pharmaceutical
On August 3, 20021year, it passed the evaluation of national technological innovation demonstration enterprises in 20021year.
In September, 20021year, it was shortlisted in the list of top enterprises in social responsibility 100 of private enterprises in Hebei province.
202 1, 10, 1 1 was selected as "Top 100 Innovative Enterprises of Strategic Emerging Industries in Hebei Province in 20021year" issued by Hebei High-tech Industry Association.
In June, 2022, 1 year, it won the title of "Excellent Brand of Listed Company in 2026,5438+0".
In June, 2022, 5438+1October won the "20021Top Ten Enterprises in China (Industry)" award and was selected as one of the top 500 listed companies in China in June, 5438+0.
On June 28th, 2022, 65438 National Development and Reform Commission and other departments issued a notice on printing and distributing 202 1 (the 28th batch) and the list of all state-level enterprise technology centers, which showed that the enterprise technology center was qualified as a state-level enterprise technology center.
In February, 2022, it was publicized as the shortlist of the second batch of characteristic service export bases (Chinese medicine).
On August 1 day, 2022, he was selected into the public list of candidates to be recommended by "National Advanced Private Enterprises in Employment and Social Security".
In June 2022, Yiling Pharmaceutical was identified as a new batch of national intellectual property demonstration enterprises.